Anil Kumar Marapaka

Anil Kumar Marapaka's research focuses on designing and structurally characterizing small-molecule inhibitors that block enzymes used by pathogens (bacteria and malaria parasites) to survive or cause disease, such as carbonic anhydrases and aminopeptidases. This work combines medicinal chemistry (making and optimizing candidate drug molecules) with structural biology (using crystal structures to see how inhibitors bind their targets) to support development of new antibacterial and antimalarial treatments. Recent work has extended to using nanotechnology-based approaches for environmental applications.

Publication output was higher around 2017-2018 (5-7 papers/year) and has since slowed to roughly 0-2 papers per year over the last five years.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026